• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SCARBOROUGH INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO; IVD FOR HIV AG/AB Back to Search Results
Catalog Number 7D2648
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Codes No Known Impact Or Consequence To Patient (2692); No Information (3190)
Date of Event 12/27/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Testing was performed at alere (b)(4) on retained kit lot 170223 with the following internal whole blood control samples: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lot 170223 were reviewed.This lot met the required release specifications.A review of the complaints reported false positive or unconfirmed false positive related to lot number 170223 showed that the complaint rate is (b)(4).The evidence available does not indicate that the product is performing outside label claims.Alere (b)(4) was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that this device lot is performing within labeled claims.
 
Event or Problem Description
A (b)(6) ab result was reported on a blood sample tested with the alere determine hiv 1/2 ag/ab combo.The patient was confirmed (b)(6) by (b)(6), 4th generation eia, and rna pcr.There is insufficient information to determine if a malfunction occurred.The patient gender, pregnancy status, treatment and patient outcome were unknown.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by alere (b)(4); however, this mdr is a retrospective filing in response to an observation from an fda inspection conducted february 26th to march 2nd, 2018 at alere (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV 1/2 AG/AB COMBO
Common Device Name
IVD FOR HIV AG/AB
Manufacturer (Section D)
ALERE SCARBOROUGH INC.
10 southgate road
scarborough ME 04074
MDR Report Key7598597
Report Number1221359-2018-00309
Device Sequence Number1187523
Product Code MZF
UDI-Device Identifier07290015003735
UDI-Public010729001500373510170223
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
BP120037-0
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 06/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/15/2018
Device Catalogue Number7D2648
Device Lot Number170223
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/30/2018
Initial Report FDA Received Date06/13/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-